FDA Inspection 1215034 — Granules Pharmaceuticals Inc.
The FDA completed an inspection of Granules Pharmaceuticals Inc. on August 3, 2023 in Chantilly, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 3, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chantilly, VA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)